Teva Announces Launch of a Generic Version of Letairis® (ambrisentan) Tablets in the United States

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. MU
5. APGE
6. ABBV
7. DFTX
8. RGNX
9. GOOGL
10. LCO

Go back to Teva Announces Launch of a Generic Version of Letairis® (ambrisentan) Tablets in the United States
TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) Delayed: 31.96 +0.48 (1.52%)
Previous Close $31.48    52 Week High $66.55 
Open $31.37    52 Week Low $37.82 
Day High $31.96    P/E N/A 
Day Low $31.28    EPS $0.00 
Volume 1,602,631       

TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) Delayed: 31.96 +0.48 (1.52%)
Previous Close $31.48    52 Week High $66.55 
Open $31.37    52 Week Low $37.82 
Day High $31.96    P/E N/A 
Day Low $31.28    EPS $0.00 
Volume 1,602,631